JCR Pharma Of Japan Sells Shares, Two Drug Rights To GSK
This article was originally published in PharmAsia News
Executive Summary
Japan's JCR Pharma plans to sell a chunk of shares to U.K.-based GlaxoSmithKline, making GSK its second-largest shareholder